Dissecting the US FDA's new guidance on PDUFA user fee waivers, reductions and refunds
This article was originally published in SRA
Executive Summary
Michelle L Butler and Kurt R Karst highlight the main points of new draft guidance that is the culmination of 18 years' experience.